about
Slowed Prosaccades and Increased Antisaccade Errors As a Potential Behavioral Biomarker of Multiple System Atrophy.Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.Models of multiple system atrophyParkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutationsDrug-induced parkinsonism in the elderly: incidence, management and prevention.Co-occurrence of parkinsonism and dementia in clinical practice: relevant differential diagnoses.Clinical trials: past, current, and future for atypical Parkinsonian syndromes.Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.Quality of life in patients with progressive supranuclear palsy: one-year follow-up.Primary motor cortex long-term plasticity in multiple system atrophy.Neurodegenerative disease: can synucleinopathy and tauopathy be identified during life?Nocturnal manifestations of atypical and vascular parkinsonism: how do they differ from Parkinson's disease?Evaluation of an optimized [18 F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders.Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.Treatment options for tauopathies.
P2860
Q33813931-8D01AA8F-4451-41BF-BF13-EC3A1B4CC9FBQ34625773-E6E3FF6A-391C-43C8-A30F-FC63103B1BB1Q35006611-4A069FEC-6E28-44B6-BF41-851B385868EBQ36513407-9F154341-D02C-410B-B512-AFCDD036BEE8Q37687866-9C916F6D-07F0-4393-911A-E85A1D99EBE3Q37976411-05AD2F04-812D-4177-9925-58E32F5EB2F9Q37978747-CC3117F7-8714-444A-A14B-E0FC7A4C28A9Q38223118-6050FB0C-905A-4D7E-9609-A3FFC171F17EQ41433471-BC2EEAB8-DAC6-48F2-B84A-B6370080FB9FQ41674282-903F7982-1A25-400D-A6C1-E95CB53E5579Q46607741-721CB535-D8D3-486A-8A4D-F29CF1B01A2DQ48002290-E6CC977F-C329-428D-8176-6367CB2AAC35Q48117277-AC50C330-28B3-4CFA-A258-F52BB236F470Q48288388-F0486B0C-3E45-4C38-ADBA-D7FB28D44246Q50093660-C0896EDA-2BF7-4483-906D-54048C4A8DCAQ53326015-0ECEF586-CD13-4C26-A209-B2DAB1BC9436
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Milestones in atypical and secondary Parkinsonisms.
@en
Milestones in atypical and secondary Parkinsonisms.
@nl
type
label
Milestones in atypical and secondary Parkinsonisms.
@en
Milestones in atypical and secondary Parkinsonisms.
@nl
prefLabel
Milestones in atypical and secondary Parkinsonisms.
@en
Milestones in atypical and secondary Parkinsonisms.
@nl
P2860
P50
P356
P1433
P1476
Milestones in atypical and secondary Parkinsonisms.
@en
P2860
P304
P356
10.1002/MDS.23713
P407
P577
2011-05-01T00:00:00Z